Philadelphia biotech firm acquired for $78M by North Carolina company with eye on cancer treatment
The North Carolina biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Cameron Snipes Source Type: news
More News: Biotechnology | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Health Management | Neurology